Global Markets
The excitement around Moderna’s cancer vaccine is cooling. Here’s why.
Investors had “incredibly high” expectations around the Phase 3 data for the drugmaker’s experimental cancer treatment.
Investors had “incredibly high” expectations around the Phase 3 data for the drugmaker’s experimental cancer treatment.
🔥 Get India’s hottest story up to 4× a day, plus a daily alert on your rights.
📡 Verified Wire Agency
Original Resource
Comments 0